Literature DB >> 11511975

Paraoxonase gene polymorphisms and coronary reactivity in young healthy men.

R Malin1, J Knuuti, T Janatuinen, R Laaksonen, R Vesalainen, P Nuutila, H Jokela, J Laakso, O Jaakkola, T Solakivi, T Lehtimäki.   

Abstract

This study examined the relationships between paraoxonase genotypes, coronary artery reactivity, and indices of low-density lipoprotein oxidation in healthy men. Impairment in coronary flow reserve, as assessed by positron emission tomography, is associated with lipoprotein oxidation, which is affected by high-density lipoprotein bound enzyme, paraoxonase. Paraoxonase has two common polymorphisms (M/L55 and R/Q192) that change the activity of the enzyme. Forty-nine healthy men (mean age 35 +/- 4 years) were divided by paraoxonase genotype into low (Q192/Q192, or M55/M55, M55/L55) and high-active (R192/Q192, R192/R192, or L55/L55) groups and related to the myocardial blood flow, to the susceptibility of low-density lipoprotein to oxidation, and the autoantibody titer against oxidized low-density lipoprotein. The blood flow was measured by positron emission tomography at rest and during adenosine infusion. The low-active Q192/Q192 genotype was associated with higher resting blood flow corrected for rate-pressure product compared to the high-active R192/R192 and R192/Q192 genotypes (P=0.011). The blood flow stimulated by adenosine was not significantly different in the low- and high-active genotype groups. Paraoxonase genotypes had no effect on low-density lipoprotein susceptibility to oxidation or autoantibody formation against oxidized low-density lipoprotein. Genotypes of paraoxonase may not clearly contribute to the early changes in coronary reactivity. Coronary vasomotor tone at rest appears to be modulated by paraoxonase R/Q192 polymorphism through mechanism(s) unrelated to low-density lipoprotein oxidation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511975     DOI: 10.1007/s001090100232

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  8 in total

1.  Insecticides and atherosclerosis.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2001-08       Impact factor: 4.599

2.  Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.

Authors:  H Karsen; I Binici; M Sunnetcioglu; A I Baran; M R Ceylan; S Selek; H Celik
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

Review 3.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

4.  Measurement of heritability of myocardial blood flow by positron emission tomography: the Twins Heart Study.

Authors:  Shaoyong Su; John Votaw; Tracy Faber; Durreshahwar Khan; J Douglas Bremner; Jack Goldberg; Ken Nichols; Andrew Van Tosh; Viola Vaccarino
Journal:  Heart       Date:  2012-02-09       Impact factor: 5.994

Review 5.  Paraoxonase gene polymorphisms, oxidative stress, and diseases.

Authors:  Hong-Liang Li; De-Pei Liu; Chih-Chuan Liang
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

6.  Effects of paraoxonase activity and gene polymorphism on coronary vasomotion.

Authors:  Vincent Dunet; Juan Ruiz; Gilles Allenbach; Paola Izzo; Richard W James; John O Prior
Journal:  EJNMMI Res       Date:  2011-11-18       Impact factor: 3.138

7.  Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction.

Authors:  Mohamed F Abdel Rahman; Ingy M Hashad; Khaled Abou-Aisha; Sahar M Abdel-Maksoud; Mohamed Z Gad
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

8.  Q192R Paraoxonase (PON)1 Polymorphism, Insulin Sensitivity, and Endothelial Function in Essential Hypertensive Men.

Authors:  Giulia Dell'Omo; Giuseppe Penno; Laura Pucci; Daniela Lucchesi; Stefano Del Prato; Roberto Pedrinelli
Journal:  Clin Med Insights Cardiol       Date:  2014-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.